System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Jiangyuan Zhou is an expert in Pediatrics at West China Hospital of Sichuan University (China). As of August 2026, ScienceLeadR ranks Jiangyuan Zhou in the top 1% of experts worldwide for Hemangioma. Jiangyuan Zhou has authored 64 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 309 (community average: 125). How the SLR is computed.

LeadR Profile

Jiangyuan Zhou West China Hospital of Sichuan University China
309 ScienceLeadR Reputation 309

Unlock

Register Login
Network Map

Pediatrics

Subspecialties: Dermatology - Hematology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2019 - 2026
Source: PubMed

West China Hospital of Sichuan University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 64

Citations

Citations: 408 1st author: 12 Last author: 1 Unique author: 0

Main journals

J Am Acad Dermatol 9
Orphanet J Rare Dis 6
Front Pediatr 4
Pediatr Blood Cancer 4
Int J Cancer 3

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
High Responsiveness of Head and Neck Kaposiform Hemangioendothelioma Without Kasabach-Merritt Phenomenon to Sirolimus Monotherapy.
PMID 42657977 — kasabach-merritt syndrome, hemangioendothelioma, neoplasms, disease progression, sirolimus, therapeutics, wounds and injuries		Pediatr Blood Cancer20260
Propranolol monotherapy versus propranolol plus prednisone for diffuse infantile hepatic haemangioma: a randomized clinical trial.
PMID 42449025 — propranolol, prednisone, drug-related side effects and adverse reactions, therapeutics, pediatrics		World J Pediatr20260
Incidence, clinical characteristics and risk factors for infantile hemangioma ulceration after oral propranolol initiation: a retrospective study.
PMID 42250725 — hemangioma, propranolol, incidence, retrospective studies, risk factors		J Am Acad Dermatol20260
Tufted angioma.
PMID 42235597 — pediatrics, dermatology		J Am Acad Dermatol20260
A 2-Month-Old Boy With Respiratory Distress, Thrombocytopenia, and an Aggressive Mediastinal Mass.
PMID 41963021 — thoracic diseases, blood platelets, thrombocytopenia		Chest20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 4
N/A 2
Phase 2/Phase 3 1
Phase 3 1

By status:

Completed 4
Recruiting 3
Not yet recruiting 1

By type:

Interventional 7
Observational 1

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma
NCT07131644 — hemangioendothelioma, sirolimus		Phase 2Recruiting2025
Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
NCT06673290 — congenital abnormalities, safety, pharmaceutical preparations, lymphatic abnormalities, sirolimus, therapeutics, lymphangioma		Phase 2/Phase 3Recruiting2024
Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma
NCT05324384 — kasabach-merritt syndrome, sarcoma, kaposi, pharmaceutical preparations, hemangioendothelioma, sirolimus, maintenance, sarcoma, therapeutics		Phase 2Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS